Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Neurologia I Neurochirurgia Polska|November 8, 2005
[A case of a giant cavernoma located in the temporal region]Paweł Słoniewski, Karina Smida, Michal Rynkowski, et al.
Bulletin Du Cancer|July 26, 2013
[Glutamate and malignant gliomas, from epilepsia to biological aggressiveness: therapeutic implications]Serge Blecic, Michal Rynkowski, Olivier De Witte, et al.
Oncotarget|June 15, 2012
Voltage-dependent K+ channels as oncotargets in malignant gliomasFlorence Lefranc, Henri-Benjamin Pouleau, Michal Rynkowski, et al.
Minimally Invasive Surgery|September 13, 2012
Minimally invasive spinal arthrodesis in osteoporotic population using a cannulated and fenestrated augmented screw: technical description and clinical experienceAlphonse Lubansu, Michal Rynkowski, Laurence Abeloos, et al.
Neurosurgical Review|June 7, 2011
Long-term follow-up survey reveals a high yield, up to 30% of patients presenting newly detected aneurysms more than 10 years after ruptured intracranial aneurysms clippingMichaël Bruneau, Michal Rynkowski, Karina Smida-Rynkowska, et al.
Neurosurgical Review|August 25, 2012
Endoscope-integrated ICG technology: first application during intracranial aneurysm surgeryMichaël Bruneau, Geoffrey Appelboom, Michal Rynkowski, et al.
Neurosurgery|February 23, 2010
Cervical vertebral artery rerouting: a technique for releasing kinks and restoring endovascular accessMichaël Bruneau, Boris Lubicz, Benoit J Pirotte, et al.
Musculoskeletal Science & Practice|April 9, 2026
Stop guessing: A clinician's guide to demystifying spine-related arm pain in primary careRenaud Hage, Corentin Denis, Antoine Fourré, et al.
Functional Neurology|July 20, 2007
Factors affecting the health-related quality of life of patients with cervical dystonia and the impact of botulinum toxin type A injectionsJaroslaw Slawek, Andrzej Friedman, Anna Potulska, et al.
Neoplasia (New York, N.Y.)|September 9, 2010
Long-term in vitro treatment of human glioblastoma cells with temozolomide increases resistance in vivo through up-regulation of GLUT transporter and aldo-keto reductase enzyme AKR1C expressionBenjamin Le Calvé, Michal Rynkowski, Marie Le Mercier, et al.
Pageof 2